Please ensure Javascript is enabled for purposes of website accessibility
White House Faces Skepticism Over Prospects for a Vaccine
gvw_ap_news
By Associated Press
Published 4 years ago on
September 4, 2020

Share

Could the U.S. really see a coronavirus vaccine before Election Day?

A letter from federal health officials instructing states to be ready to begin distributing a vaccine by Nov. 1 — two days before the election — has been met, not with exhilaration, but with suspicion among some public health experts, who wonder whether the Trump administration is hyping the possibility or intends to rush approval for political gain.

The skepticism comes amid growing questions about the scientific credibility of the Food and Drug Administration and the Centers for Disease Control and Prevention, and their vulnerability to political pressure from President Donald Trump.

The skepticism comes amid growing questions about the scientific credibility of the Food and Drug Administration and the Centers for Disease Control and Prevention, and their vulnerability to political pressure from President Donald Trump.

Dr. Anthony Fauci, the government’s top infectious-disease expert and a member of Trump’s coronavirus task force, told CNN on Thursday that it is unlikely but “not impossible” that a vaccine could win approval in October, instead of November or December, as many experts believe.

“And I would assume, and I’m pretty sure, it’s going to be the case that a vaccine would not be approved for the American public unless it was indeed both safe and effective,” he said.

Similarly, Dr. Moncef Slaoui, chief adviser to Operation Warp Speed, the administration’s project to hasten the development of a vaccine, told NPR that it is possible but “extremely unlikely” a vaccine will be ready before the election.

Preparations for a Possible Early Vaccine Do Not Necessarily Mean That an Answer Will Come Sooner

White House spokeswoman Kayleigh McEnany, meanwhile, gave assurances that Trump “will not in any way sacrifice safety” when it comes to a vaccine. And executives of five top pharmaceutical companies pledged that no COVID-19 vaccines or treatments will be approved, even for emergency use, without proof they are safe and effective.

The concerns were set off by a letter dated Aug. 27 in which CDC Director Robert Redfield asked the nation’s governors to help government contractor McKesson Corp. set up vaccine distribution facilities so that they are up and running by Nov. 1. Redfield did not say a vaccine would be ready by then.

Some longtime scientific advisers to the government said the CDC’s preparations for a possible early vaccine do not necessarily mean that an answer will come sooner or that there will be a rush to judgment about whether one works.

“Being prepared for early success … is actually prudent,” said Dr. Steven Nissen, a Cleveland Clinic cardiologist. If a vaccine is working, “you want to be prepared to act on the information.”

Still, to some public health experts, the timing of the letter smacked of a political stunt by a president facing a tough reelection.

“I think it’s almost a certainty,” said Ashish Jha, dean of the Brown University School of Public Health. He said November “feels awfully early.”

Jha noted the FDA’s recent move to approve emergency use of convalescent plasma against COVID-19 following threats and complaints from Trump about the slow pace of the agency’s review.

Senate Democratic Leader Chuck Schumer Questioned the Trump Administration’s Motives

Last week, FDA Commissioner Stephen Hahn was forced to correct himself after overstating the lifesaving benefits of the plasma treatment. The CDC also came under fire from scientists in recent days for quietly updating its guidelines to suggest fewer Americans need to get tested for the virus.

“Too much of the evidence points to the Trump administration pressuring the FDA to approve a vaccine by Election Day to boost the president’s reelection campaign. This raises serious safety concerns about politics, not science and public health, driving the decision making process.” — Senate Democratic leader Chuck Schumer

Jha said the stakes here are much higher.

“You want to have pretty good safety data on vaccines,” he said. “So I am deeply worried that that’s not what is going to happen.”

Senate Democratic leader Chuck Schumer questioned the Trump administration’s motives.

“Too much of the evidence points to the Trump administration pressuring the FDA to approve a vaccine by Election Day to boost the president’s reelection campaign,” he said in a statement. “This raises serious safety concerns about politics, not science and public health, driving the decision making process.”

Three COVID-19 vaccines are undergoing final-stage, or Phase 3, clinical trials in the U.S. Each study is enrolling about 30,000 people who will get two shots, three weeks apart, and then will be monitored for coronavirus infections and side effects for anywhere from a week to two years.

The FDA will not be able to even consider a vaccine until certain key steps occur.

First, independent experts on what are known as data safety monitoring boards, or DSMBs, will have to rule that they have collected enough information to draw firm conclusions about a vaccine’s performance. Then the experts will make the data available to the manufacturer, which will decide whether to submit it for FDA approval.

Whether and when to stop a study early is up to a DSMB, whose scientists see a study’s results as they are accumulating. The company does not.

Countries Around the World Are Racing To Develop a Vaccine

“We will not cut corners,” Pfizer CEO Albert Bourla vowed Thursday in a call with reporters, hosted by a pharmaceutical industry group. Chief executives from Merck, Roche, Eli Lilly and Gilead Sciences agreed, adding that extra transparency on the test results and approval process is needed.

Bourla said that as of Wednesday, the company’s late-stage study, which started at the end of July, had enrolled about 23,000 people, some of whom had already received the second dose. He said he expects by the end of October to have enough participants infected by the virus to tell whether the vaccine works — an extremely fast timeline.

Countries around the world are racing to develop a vaccine. Russian President Vladimir Putin announced Aug. 11 that his country had become the first to approve one, but scientists reacted skeptically because the shots had been tested on just a few dozen people.

Alex Azar, Trump’s secretary of Health and Human Services, gave assurances that any decision to release a vaccine in the U.S. would be based on the data and the “FDA’s gold standards.”

And he accused those questioning the Nov. 1 date of partisanship.

“I think it’s very irresponsible how people are trying to politicize notions of delivering a vaccine to the American people,” he told CBS. “We already have a significant challenge in this country with vaccine hesitancy. And efforts to undermine confidence in a vaccine … hurt in terms of people being willing to take a vaccine once it comes through.”

RELATED TOPICS:

DON'T MISS

Whitey Herzog, Hall of Fame Manager Who Led Cardinals to 1980s Success, Dies at 92

DON'T MISS

Coalinga-Huron Teachers Say They’ll Strike Unless a Fair Contract Is Offered

DON'T MISS

Coalition: CA Lawmakers Need to Roll Back Proposed ‘Utility Tax’

DON'T MISS

CA’s High Construction Costs Limit Housing. A Supreme Court Decision Might Help

DON'T MISS

Now’s the Time to Register for FUSD’s Free Preschool and T-K

DON'T MISS

‘Hopeville’ Literacy Documentary Showing Tonight at Roosevelt High

DON'T MISS

Michigan Faces Probation for Football Recruiting Violations; Case vs. Jim Harbaugh Pending

DON'T MISS

What Winnie the Pooh and Mickey Mouse Can Tell Us About the Public Domain and Remix Culture

DON'T MISS

Acquisition of Historic Fresno Real Estate Brand Creates Area’s Largest Brokerage

DON'T MISS

Wall Street’s Mixed Trading Day

UP NEXT

New Recruiting Programs Put Army, Air Force on Track to Meet Enlistment Goals. Navy Will Fall Short

UP NEXT

Justice Thomas Misses Supreme Court Session Monday With No Explanation

UP NEXT

‘Civil War’ Declares Victory at the Box Office, Toppling ‘Godzilla X Kong’

UP NEXT

Scheffler Turns the Masters Into Another Sunday Yawner With a Dominating Win

UP NEXT

Vegas, US Tour and More Signings: Wrexham Has Plenty of Fun and Work Ahead After Latest Promotion

UP NEXT

NBA Play-in Game Preview: West Games on Tuesday, East Games on Wednesday, Eliminations on Friday

UP NEXT

Ship That Caused Bridge Collapse Had Apparent Electrical Issues While Still Docked, Source Says

UP NEXT

The Latest | World Leaders Urge Israel Not to Retaliate for the Iranian Drone and Missile Attack

UP NEXT

US Shoots Down Iran-Launched Attack Drones as Biden Team Pledges ‘Support’ for Israel

UP NEXT

A Mission of Mercy, Then a Fatal Strike: How an Aid Convoy in Gaza Became Israel’s Target

CA’s High Construction Costs Limit Housing. A Supreme Court Decision Might Help

10 hours ago

Now’s the Time to Register for FUSD’s Free Preschool and T-K

Local Education /

10 hours ago

‘Hopeville’ Literacy Documentary Showing Tonight at Roosevelt High

Local Education /

11 hours ago

Michigan Faces Probation for Football Recruiting Violations; Case vs. Jim Harbaugh Pending

11 hours ago

What Winnie the Pooh and Mickey Mouse Can Tell Us About the Public Domain and Remix Culture

11 hours ago

Acquisition of Historic Fresno Real Estate Brand Creates Area’s Largest Brokerage

Breaking News /

12 hours ago

Wall Street’s Mixed Trading Day

12 hours ago

It’s ‘Signing Day’ for These Clovis Unified Youngsters

Local Education /

12 hours ago

Clovis Armed Robbery and Pursuit Result in 3 Arrests, 1 Suspect Still at Large

12 hours ago

Charges Against Trump and Jan. 6 Rioters at Stake as Supreme Court Hears Debate Over Obstruction Law

12 hours ago

Whitey Herzog, Hall of Fame Manager Who Led Cardinals to 1980s Success, Dies at 92

NEW YORK — Whitey Herzog, the gruff and ingenious Hall of Fame manager who guided the St. Louis Cardinals to three pennants and a World Seri...

5 hours ago

5 hours ago

Whitey Herzog, Hall of Fame Manager Who Led Cardinals to 1980s Success, Dies at 92

6 hours ago

Coalinga-Huron Teachers Say They’ll Strike Unless a Fair Contract Is Offered

9 hours ago

Coalition: CA Lawmakers Need to Roll Back Proposed ‘Utility Tax’

10 hours ago

CA’s High Construction Costs Limit Housing. A Supreme Court Decision Might Help

Local Education /
10 hours ago

Now’s the Time to Register for FUSD’s Free Preschool and T-K

Local Education /
11 hours ago

‘Hopeville’ Literacy Documentary Showing Tonight at Roosevelt High

11 hours ago

Michigan Faces Probation for Football Recruiting Violations; Case vs. Jim Harbaugh Pending

11 hours ago

What Winnie the Pooh and Mickey Mouse Can Tell Us About the Public Domain and Remix Culture

MENU

CONNECT WITH US

Search

Send this to a friend